Paralyzed man walks again after experimental drug trial triggers remarkable recovery
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to […]
Bariatric surgery results in more weight loss compared to GLP-1s, says new study after Carnie Wilson’s ‘scary’ ordeal
The Journal of the American Medical Association (JAMA) recently published research showing that bariatric surgery results in more significant weight loss and lower long-term costs compared to GLP-1 medications. Experts discuss the effectiveness of various weight-loss surgeries.
GLP-1-friendly snacks: protein-packed NPD
Weightloss drugs are changing the way people snack and brands are answering with protein-packed launches designed to keep cravings at bay while delivering serious flavor.
The GLP-1 Arms Race, Explained
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?
RareFoldGPCR: Agonist Design Beyond Natural Amino Acids
Noncanonical amino acids (NCAAs) expand the chemical diversity of peptides beyond the twenty standard residues, offering new opportunities for designing binders with novel interaction modes and functional activity. G protein-coupled receptors (GPCRs) are central to cellular signalling and represent one of the largest classes of therapeutic targets, yet their functional modulation remains challenging. Here, we […]
Semaglutide Shows Safety in Patients on Dialysis
The study is the largest of its kind reporting on GLP-1 treatment in patients on dialysis, who are commonly excluded from clinical trials. Medscape Medical News
Semaglutide Shows Safety in Patients on Dialysis
The study is the largest of its kind reporting on GLP-1 treatment in patients on dialysis, who are commonly excluded from clinical trials. Medscape Medical News
Fitness Revolution Investment Thesis
I’m of the belief that a health revolution is gripping the young population of America and other developing nations, with people becoming far more conscious than generations past of what they put into their bodies as well as what physical exercise they perform. I think this is driven by a few different factors (in no […]
Can Novo Nordisk’s Restructuring Program Drive its Return to Growth?
In September 2025, Novo Nordisk NVO, under the leadership of its new CEO Mike Doustdar, unveiled a major restructuring plan designed to restore momentum in its core businesses and counter mounting competitive pressures. The plan, effective immediately, focuses on streamlining operations, accelerating decision-making speed and redeploying resources toward the company’s two main growth engines — […]
Menopause Weight Gain Is Common, but GLP-1s, Other Strategies Can Help
For some females experiencing menopause weight gain, dietary changes may not be enough on their own. Getty Images/Cultura Creative More women are seeking solutions to manage menopause symptoms like weight gain, highlighting a growing need for effective therapies and treatments. Lifestyle modifications like a healthy diet can help, but GLP-1 drugs have also emerged as […]